Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 20 of 238 Results
All Results
A Pharmacokinetic and Safety study comparing Fluticasone Propionate and Albuterol Sulfate to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old
- Condition(s):
- Respiratory
- Status:
- Recruiting
- Requirements:
- 4 Years to 11 Years
- Interventions:
- Drug: TEV-56248
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 50 Years
- Interventions:
- Drug: laquinimod 0.3 | Drug: laquinimod 0.6 | Other: Placebo
A Study to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy Safety and Efficacy Study (TOPAS-MSA)
- Condition(s):
- Multiple System Atrophy
- Status:
- Recruiting
- Requirements:
- 30 Years and older
- Interventions:
- Drug: TEV-56286 (emrusolmin, anle138b)
A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
- Condition(s):
- Vitiligo
- Status:
- Recruiting
- Requirements:
- 18 Years to 75 Years
- Interventions:
- Drug: TEV-53408
Absolute Bioavailability of Reslizumab in Healthy Subjects
- Condition(s):
- Absolute Bioavailability
- Status:
- Completed
- Requirements:
- 18 Years to 45 Years
- Interventions:
- Drug: Reslizumab IV | Drug: Reslizumab SC
Adenovirus Vaccine Pregnancy Registry
- Condition(s):
- Adenovirus
- Status:
- Withdrawn
- Requirements:
- 17 Years to 50 Years
Albuterol HFA MDI in Pediatric Participants With Asthma
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 4 Years to 11 Years
- Interventions:
- Drug: Albuterol | Drug: Placebo | Drug: Proventilֲ® HFA
An Efficacy and Safety Profile of Inhaled TV48108 in Healthy Volunteers and COPD Patients
- Condition(s):
- Chronic Obstructive Pulmonary Disease
- Status:
- Terminated
- Requirements:
- 20 Years to 75 Years
- Interventions:
- Drug: TV48108 | Drug: Placebo
An Efficacy and Safety Study of Fremanezumab in Adults With Migraine
- Condition(s):
- Migraine Prophylaxis
- Status:
- Completed
- Requirements:
- 18 Years to 70 Years
- Interventions:
- Drug: Fremanezumab | Drug: Placebo
Assess Safety and PK of ADASUVE® in Children and Adolescents Using an Antipsychotic Medication
- Condition(s):
- BiPolar
- Status:
- Completed
- Requirements:
- 10 Years to 17 Years
- Interventions:
- Drug: ADASUVEֲ®
Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older
- Condition(s):
- Seasonal Female, Maleergic Rhinitis | Hayfever
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Beclomethasone dipropionate HFA Nasal Aerosol | Drug: Placebo
Assess the Efficacy, Safety and Tolerability of Glatiramer Acetate Compared to Placebo
- Condition(s):
- Relapsing Remitting Multiple Sclerosis
- Status:
- Completed
- Requirements:
- 18 Years to 55 Years
- Interventions:
- Drug: Glatiramer acetate (GA) | Drug: Placebo
Assess Tolerability, Safety and Pharmacology of hGH-ViaDerm™ System in Adults With GH-Deficiency
- Condition(s):
- Growth Hormone Deficiency
- Status:
- Completed
- Requirements:
- 20 Years to 60 Years
- Interventions:
- Drug: hGH-ViaDermג„¢ System (hGH or somatropin) | Device: hGH-ViaDermג„¢ System
Assessment of LBR-101 In Chronic Migraine
- Condition(s):
- Chronic Migraine
- Status:
- Completed
- Requirements:
- 18 Years to 65 Years
- Interventions:
- Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo
Azilect + Antidepressant Chart Review
- Condition(s):
- Serotonin Syndrome
- Status:
- Completed
- Requirements:
- Child, Adult, Older Adult
- Interventions:
- Drug: Group R+AD Rasagiline + Antidepressant | Drug: Group R Rasagiline | Drug: Group AD Anti-PD + Antidepressant
Azilect® In Wearing-Off
- Condition(s):
- Parkinson's Disease
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: Azilectֲ®
Balugrastim (Neugranin) in Breast Cancer Participants Receiving Doxorubicin/Docetaxel
- Condition(s):
- Chemotherapy-induced Neutropenia
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Biological: Neugranin | Drug: Pegfilgrastim | Drug: Chemotherapy
Beclomethasone Dipropionate in Participants At Least 12 Years Old With Persistent Asthma
- Condition(s):
- Asthma
- Status:
- Completed
- Requirements:
- 12 Years and older
- Interventions:
- Drug: Beclomethasone dipropionate | Drug: Placebo | Drug: Albuterol/salbutamol
Bendamustine Hydrochloride and Rituximab Compared With R-CVP or R-CHOP in Patients With Lymphoma
- Condition(s):
- Non-Hodgkin's Lymphoma | Mantle Cell Lymphoma
- Status:
- Completed
- Requirements:
- 18 Years and older
- Interventions:
- Drug: bendamustine | Drug: rituximab | Drug: vincristine | Drug: prednisone | Drug: cyclophosphamide | Drug: doxorubicin
Bendamustine Hydrochloride for the Treatment of Relapsed or Refractory Acute Leukemia
- Condition(s):
- Leukemia
- Status:
- Completed
- Requirements:
- 1 Year to 20 Years
- Interventions:
- Drug: Bendamustine
